CoChat

Lapatinib and doxorubicin enhance the Stat1‐dependent antitumor immune response

Hannesdóttir, Lára, Tymoszuk, Piotr, Parajuli, Nirmala, Wasmer, Marie‐Helene, Philipp, Sonja, Daschil, Nina, Datta, Sebak, Koller, Johann‐Benedikt, Tripp, Christoph H., Stoitzner, Patrizia, Müller‐Holzner, Elisabeth, Wiegers, Gerrit Jan, Sexl, Veronika, Villunger, Andreas, Doppler, Wolfgang · 2013 · European Journal of Immunology
Cited by 113

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The dual erb B 1/2 tyrosine kinase inhibitor lapatinib as well as the anthracycline doxorubicin are both used in the therapy of HER 2‐positive breast cancer. Using MMTV‐neu mice as an animal model for HER 2‐positive breast cancer, we observed enhanced tumor infiltration by IFN‐γ‐secreting T cells after treatment with doxorubicin and/or lapatinib. Antibody depletion experiments revealed a contribution of CD 8+ but not CD 4+ T cells to the antitumor effect of these drugs. Doxorubicin treatment additionally decreased the content of immunosuppressive tumor‐associated macrophages (TAM s) in the tumor bed. In contrast, S tat1‐deficient mice were resistant to tumor growth inhibition by lapatinib and/or doxorubicin and exhibited impaired T‐cell activation and reduced T‐cell infiltration of the tumor in response to drug treatment. Furthermore, S tat1‐deficiency resulted in reduced expression of the T‐cell chemotactic factors CXCL 9, CXCL 10, and CXCL 11 in the tumor epithelium. The inhibition of TAM infiltration of the tumor by doxorubicin and the immunosuppressive function of TAM s were found to be S tat1 independent. Taken together, the results point to an important contribution toward enhancing T‐cell and IFN‐γ‐based immunity by lapatinib as well as doxorubicin and emphasize the role of S tat1 in building an effective antitumor immune response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/eji.201242505

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

Metadata

Authors
Hannesdóttir, L., Tymoszuk, P., Parajuli, N., Wasmer, M., Philipp, S., Daschil, N., Datta, S., Koller, J., Tripp, C. H., Stoitzner, P., Müller‐Holzner, E., Wiegers, G. J., Sexl, V., Villunger, A., & Doppler, W.
Venue
European Journal of Immunology
Publisher
Wiley
Published
2013-07-11
Volume
43
Issue
10
Pages
2718-2729
ISSN
  • 0014-2980 (ISSN-L)
  • 1521-4141
OpenAlex
W1546466517
Cited by
113
References
7
FWCI
5.69
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.